(Q41118371)

27 September 2017

title

Involvement of CYP3A4 and CYP2D6 in the metabolism of haloperidol (English)

1 reference

27 September 2017

Fang J

1

1 reference

27 September 2017

Baker GB

series ordinal

2

1 reference

27 September 2017

Silverstone PH

series ordinal

3

1 reference

27 September 2017

Coutts RT

series ordinal

4

1 reference

27 September 2017

publication date

1 April 1997

1 reference

Cellular and Molecular Neurobiology

27 September 2017

published in

1 reference

27 September 2017

volume

17

1 reference

27 September 2017

issue

2

1 reference

27 September 2017

page(s)

227-233

1 reference

Oxidation of reduced haloperidol to haloperidol: involvement of human P450IID6 (sparteine/debrisoquine monooxygenase).

27 September 2017

cites work

1 reference

12 December 2020

Distribution, excretion and metabolism of neuroleptics of the butyrophenone type. I. Excretion and metabolism of haloperidol and nine related butyrophenone-derivatives in the Wistar rat

1 reference

12 December 2020

High-performance liquid chromatographic method for the detection and quantitation of haloperidol and seven of its metabolites in microsomal preparations

1 reference

12 December 2020

Elevation of plasma concentrations of haloperidol after the addition of fluoxetine

1 reference

12 December 2020

MPP(+)-like neurotoxicity of a pyridinium metabolite derived from haloperidol: in vivo microdialysis and in vitro mitochondrial studies

1 reference

12 December 2020

Identification of a potentially neurotoxic pyridinium metabolite of haloperidol in rats

1 reference

12 December 2020

Determination of 4-(4-chlorophenyl)-4-hydroxypiperidine, a metabolite of haloperidol, by gas chromatography with electron-capture detection.

1 reference

12 December 2020

Effect of quinidine on the interconversion kinetics between haloperidol and reduced haloperidol in humans: implications for the involvement of cytochrome P450IID6

1 reference

12 December 2020

Coadministration of fluvoxamine increases serum concentrations of haloperidol

1 reference

12 December 2020

Extrapyramidal symptoms in a patient taking haloperidol and fluoxetine.

1 reference

12 December 2020

Haloperidol disposition is dependent on debrisoquine hydroxylation phenotype

1 reference

12 December 2020

Dehydration is the first step in the bioactivation of haloperidol to its pyridinium metabolite

1 reference

12 December 2020

On the metabolism of haloperidol

1 reference

12 December 2020

Comparison of cytotoxicity of a quaternary pyridinium metabolite of haloperidol (HP+) with neurotoxin N-methyl-4-phenylpyridinium (MPP+) towards cultured dopaminergic neuroblastoma cells

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1026317929335

1 reference

Dimensions Publication ID

27 September 2017

1048722895

0 references

1 reference